Clinical Trial Update: ANAVEX2-73 Study in Patients With Rett Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for ANAVEX2-73 in Rett syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• ANAVEX2-73 (blarcamesine)

Snippet

Sponsor: Anavex Life Sciences Corp. | Conditions: Rett Syndrome | Phase 3 | Status: COMPLETED